216
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy

&
Pages 365-375 | Accepted 13 Nov 2009, Published online: 09 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (12)

David Azzopardi, Linsey Ellen Haswell, Justin Frosina, Michael McEwan, Nathan Gale, Jesse Thissen, Filimon Meichanetzidis & George Hardie. (2022) Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study. JMIR Research Protocols 11:10, pages e39785.
Crossref
Jeffery S Edmiston, Katy M Webb, Jingzhu Wang, Douglas Oliveri, Qiwei Liang & Mohamadi Sarkar. (2022) Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Switch to e-Vapor Products Relative to Cigarette Smoking in a 24-week, Randomized, Clinical Trial. Nicotine & Tobacco Research 24:7, pages 1047-1054.
Crossref
Min Yu, Chunshui Liang, Qianran Kong, Yihan Wang & Minmin Li. (2020) Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature. Lipids in Health and Disease 19:1.
Crossref
Douglas Oliveri, Qiwei Liang & Mohamadi Sarkar. (2020) Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm Between Adult E-Vapor Users and Adult Cigarette Smokers. Nicotine & Tobacco Research 22:7, pages 1114-1122.
Crossref
Gerhard Scherer. (2018) Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review. Regulatory Toxicology and Pharmacology 94, pages 203-233.
Crossref
Stefan Schandelmaier, Matthias Briel, Ramon Saccilotto, Kelechi K Olu, Armon Arpagaus, Lars G Hemkens & Alain J Nordmann. (2017) Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database of Systematic Reviews 2017:6.
Crossref
Mark Messina. (2016) Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients 8:12, pages 754.
Crossref
Barbara Nußbaumer, Anna Glechner, Angela Kaminski-Hartenthaler, Peter Mahlknecht & Gerald Gartlehner. (2016) Ezetimibe-Statin Combination Therapy: Efficacy and Safety as Compared With Statin Monotherapy. Deutsches Ärzteblatt international.
Crossref
Dominique Chevalier, Christine Debeuf, Gwénaële Joubrel, Martine Kocken & Nadine Planchenault. (2016) Les aliments au soja : consommation en France, qualités nutritionnelles et données scientifiques récentes sur la santé. OCL 23:4, pages D405.
Crossref
Anita Fechner, Michael Kiehntopf & Gerhard Jahreis. (2014) The Formation of Short-Chain Fatty Acids Is Positively Associated with the Blood Lipid–Lowering Effect of Lupin Kernel Fiber in Moderately Hypercholesterolemic Adults. The Journal of Nutrition 144:5, pages 599-607.
Crossref
Anatol Kontush & M. John Chapman. 2011. High‐Density Lipoproteins. High‐Density Lipoproteins 524 532 .
J.K. Prasain, S.H. Carlson & J.M. Wyss. (2010) Flavonoids and age-related disease: Risk, benefits and critical windows. Maturitas 66:2, pages 163-171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.